These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31728117)

  • 21. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative stemness and differentiation of luminal and basal breast cancer stem cell type under glutamine-deprivation.
    Jariyal H; Gupta C; Andhale S; Gadge S; Srivastava A
    J Cell Commun Signal; 2021 Jun; 15(2):207-222. PubMed ID: 33511560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen levels do not determine radiation survival of breast cancer stem cells.
    Lagadec C; Dekmezian C; Bauché L; Pajonk F
    PLoS One; 2012; 7(3):e34545. PubMed ID: 22479642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast fibroblasts in both cancer and normal tissues induce phenotypic transformation of breast cancer stem cells: a preliminary study.
    Wang B; Xi C; Liu M; Sun H; Liu S; Song L; Kang H
    PeerJ; 2018; 6():e4805. PubMed ID: 29780673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences of time-dependent microRNA expressions in breast cancer cells.
    Bozkurt SB; Ozturk B; Kocak N; Unlu A
    Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.
    Pan M; Li M; Guo M; Zhou H; Xu H; Zhao F; Mei F; Xue R; Dou J
    Exp Ther Med; 2021 Oct; 22(4):1093. PubMed ID: 34504547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition.
    Jariyal H; Gupta C; Srivastava A
    Int J Biol Macromol; 2020 Oct; 160():1078-1089. PubMed ID: 32479949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer.
    Kong Y; Lyu N; Wu J; Tang H; Xie X; Yang L; Li X; Wei W; Xie X
    J Cancer; 2018; 9(20):3728-3735. PubMed ID: 30405844
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer stemness in bone marrow micrometastases of human breast cancer.
    Kuo MC; Kothari AN; Kuo PC; Mi Z
    Surgery; 2018 Feb; 163(2):330-335. PubMed ID: 28988933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
    Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
    Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
    Li Y; Wu C
    IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
    Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.